Profile picture

Mr Timo Rusack

Luebeck (Germany)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

Beyond typical lipid suspects - identification of sphingolipid metabolism as a pharmacotherapeutic target in calcific aortic valve disease
Presentation
Beyond typical lipid suspects - identification of sphingolipid metabolism as a pharmacotherapeutic target in calcific aortic valve disease
See more
Targeting an altered sphingolipid profile with consecutive lipotoxicity as therapeutic approach to calcific aortic valve disease
Presentation
Targeting an altered sphingolipid profile with consecutive lipotoxicity as therapeutic approach to calcific aortic valve disease
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources